259 related articles for article (PubMed ID: 11830484)
21. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha.
Miller M; Shuman JD; Sebastian T; Dauter Z; Johnson PF
J Biol Chem; 2003 Apr; 278(17):15178-84. PubMed ID: 12578822
[TBL] [Abstract][Full Text] [Related]
23. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.
Lin LI; Chen CY; Lin DT; Tsay W; Tang JL; Yeh YC; Shen HL; Su FH; Yao M; Huang SY; Tien HF
Clin Cancer Res; 2005 Feb; 11(4):1372-9. PubMed ID: 15746035
[TBL] [Abstract][Full Text] [Related]
24. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].
Zhao JM; Wang HW; Xu ZF; Zhu L; Bai B; Ge XY
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):299-302. PubMed ID: 15949295
[TBL] [Abstract][Full Text] [Related]
25. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
Harada H; Harada Y; Niimi H; Kyo T; Kimura A; Inaba T
Blood; 2004 Mar; 103(6):2316-24. PubMed ID: 14615365
[TBL] [Abstract][Full Text] [Related]
26. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.
Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T
Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277
[TBL] [Abstract][Full Text] [Related]
27. Functional interaction of CCAAT/enhancer-binding-protein-α basic region mutants with E2F transcription factors and DNA.
Kowenz-Leutz E; Schuetz A; Liu Q; Knoblich M; Heinemann U; Leutz A
Biochim Biophys Acta; 2016 Jul; 1859(7):841-7. PubMed ID: 27131901
[TBL] [Abstract][Full Text] [Related]
28. A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.
Schwieger M; Löhler J; Fischer M; Herwig U; Tenen DG; Stocking C
Blood; 2004 Apr; 103(7):2744-52. PubMed ID: 14656889
[TBL] [Abstract][Full Text] [Related]
29. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.
Gombart AF; Grewal J; Koeffler HP
J Leukoc Biol; 2007 Jun; 81(6):1535-47. PubMed ID: 17347301
[TBL] [Abstract][Full Text] [Related]
30. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract][Full Text] [Related]
31. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.
Truong BT; Lee YJ; Lodie TA; Park DJ; Perrotti D; Watanabe N; Koeffler HP; Nakajima H; Tenen DG; Kogan SC
Blood; 2003 Feb; 101(3):1141-8. PubMed ID: 12393450
[TBL] [Abstract][Full Text] [Related]
32. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
33. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
Cleaves R; Wang QF; Friedman AD
Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
[TBL] [Abstract][Full Text] [Related]
34. C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1.
Cai DH; Wang D; Keefer J; Yeamans C; Hensley K; Friedman AD
Oncogene; 2008 Apr; 27(19):2772-9. PubMed ID: 18026136
[TBL] [Abstract][Full Text] [Related]
35. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines.
Morosetti R; Grignani F; Liberatore C; Pelicci PG; Schiller GJ; Kizaki M; Bartram CR; Miller CW; Koeffler HP
Blood; 1996 May; 87(10):4399-403. PubMed ID: 8639801
[TBL] [Abstract][Full Text] [Related]
36. Growth-inhibiting activity of transcription factor C/EBPalpha, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias.
Fuchs O
Folia Biol (Praha); 2007; 53(3):97-108. PubMed ID: 17580000
[TBL] [Abstract][Full Text] [Related]
37. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
38. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
39. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of the WT1 gene in myelodysplastic syndromes.
Hosoya N; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1998 Aug; 89(8):821-4. PubMed ID: 9765617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
